Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9DBI0

Entry ID Method Resolution Chain Position Source
AF-Q9DBI0-F1 Predicted AlphaFoldDB

42 variants for Q9DBI0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs233548002 16 T>A No EVA
rs3389374527 29 G>V No EVA
rs241229450 43 P>T No EVA
rs220968295 44 P>L No EVA
rs3389366763 55 V>I No EVA
rs235209322 99 R>H No EVA
rs3389377889 106 G>V No EVA
rs3389341767 116 E>K No EVA
rs3389388607 149 P>H No EVA
rs3389374450 164 Q>E No EVA
rs259630132 175 E>K No EVA
rs240562904 179 D>G No EVA
rs31537716 185 S>G No EVA
rs3406279675 189 A>D No EVA
rs3406014256 190 S>A No EVA
rs3389369648 212 I>M No EVA
rs3389388608 213 V>I No EVA
rs1132865143 229 P>L No EVA
rs3404744567 331 A>P No EVA
rs3389374445 362 P>S No EVA
rs3406013403 430 V>D No EVA
rs3389369652 456 D>N No EVA
rs3389341765 465 S>F No EVA
rs3389323285 499 E>D No EVA
rs3389323239 500 D>A No EVA
rs31534017 515 D>N No EVA
rs3389369643 524 Q>E No EVA
rs3389370762 546 K>N No EVA
rs3406483296 564 Q>H No EVA
rs3389369633 600 H>Y No EVA
rs3389351809 628 K>* No EVA
rs3389341806 636 K>* No EVA
rs3389374296 641 S>* No EVA
rs3389351825 658 P>L No EVA
rs3389366825 660 H>L No EVA
rs13463055 691 A>T No EVA
rs3389388590 716 V>M No EVA
rs3389377882 744 R>H No EVA
rs3389334848 787 C>Y No EVA
rs3412733130 799 V>A No EVA
rs3389370807 800 T>R No EVA
rs31539694 808 Q>R No EVA

No associated diseases with Q9DBI0

8 regional properties for Q9DBI0

Type Name Position InterPro Accession
domain SEA domain 86 - 209 IPR000082
domain CUB domain 335 - 452 IPR000859
domain Serine proteases, trypsin domain 576 - 811 IPR001254
repeat Low-density lipoprotein (LDL) receptor class A repeat 457 - 490 IPR002172-1
repeat Low-density lipoprotein (LDL) receptor class A repeat 490 - 527 IPR002172-2
repeat Low-density lipoprotein (LDL) receptor class A repeat 530 - 568 IPR002172-3
active_site Serine proteases, trypsin family, histidine active site 613 - 618 IPR018114
active_site Serine proteases, trypsin family, serine active site 756 - 767 IPR033116

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Single-pass type II membrane protein
  • The processed, activated two-chains form is released in the extracellular space
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
serine-type endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).

11 GO annotations of biological process

Name Definition
BMP signaling pathway The series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
cellular iron ion homeostasis Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
fibrinolysis A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
iron ion homeostasis Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
membrane protein proteolysis The proteolytic cleavage of a transmembrane protein leading to the release of its intracellular or ecto-domains.
negative regulation of BMP signaling pathway Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
proteolysis The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
self proteolysis The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their own peptide bonds.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P05049 snk Serine protease snake Drosophila melanogaster (Fruit fly) PR
Q6UWB4 PRSS55 Serine protease 55 Homo sapiens (Human) PR
P35030 PRSS3 Trypsin-3 Homo sapiens (Human) PR
Q9UI38 PRSS50 Probable threonine protease PRSS50 Homo sapiens (Human) PR
E5RG02 PRSS46P Putative serine protease 46 Homo sapiens (Human) PR
P0CW18 PRSS56 Serine protease 56 Homo sapiens (Human) PR
P15119 Mcpt2 Mast cell protease 2 Mus musculus (Mouse) PR
P98064 Masp1 Mannan-binding lectin serine protease 1 Mus musculus (Mouse) PR
Q6IE63 Prss46 Serine protease 46 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MPRCFQLPCS TRMPTTEVPQ AADGQGDAGD GEEAAEPEGK FKPPKNTKRK NRDYVRFTPL
70 80 90 100 110 120
LLVLAALVSA GVMLWYFLGY KAEVTVSQVY SGSLRVLNRH FSQDLGRRES IAFRSESAKA
130 140 150 160 170 180
QKMLQELVAS TRLGTYYNSS SVYSFGEGPL TCFFWFILDI PEYQRLTLSP EVVRELLVDE
190 200 210 220 230 240
LLSNSSTLAS YKTEYEVDPE GLVILEASVN DIVVLNSTLG CYRYSYVNPG QVLPLKGPDQ
250 260 270 280 290 300
QTTSCLWHLQ GPEDLMIKVR LEWTRVDCRD RVAMYDAAGP LEKRLITSVY GCSRQEPVME
310 320 330 340 350 360
VLASGSVMAV VWKKGMHSYY DPFLLSVKSV AFQDCQVNLT LEGRLDTQGF LRTPYYPSYY
370 380 390 400 410 420
SPSTHCSWHL TVPSLDYGLA LWFDAYALRR QKYNRLCTQG QWMIQNRRLC GFRTLQPYAE
430 440 450 460 470 480
RIPMVASDGV TINFTSQISL TGPGVQVYYS LYNQSDPCPG EFLCSVNGLC VPACDGIKDC
490 500 510 520 530 540
PNGLDERNCV CRAMFQCQED STCISLPRVC DRQPDCLNGS DEEQCQEGVP CGTFTFQCED
550 560 570 580 590 600
RSCVKKPNPE CDGQSDCRDG SDEQHCDCGL QGLSSRIVGG TVSSEGEWPW QASLQIRGRH
610 620 630 640 650 660
ICGGALIADR WVITAAHCFQ EDSMASPKLW TVFLGKMRQN SRWPGEVSFK VSRLFLHPYH
670 680 690 700 710 720
EEDSHDYDVA LLQLDHPVVY SATVRPVCLP ARSHFFEPGQ HCWITGWGAQ REGGPVSNTL
730 740 750 760 770 780
QKVDVQLVPQ DLCSEAYRYQ VSPRMLCAGY RKGKKDACQG DSGGPLVCRE PSGRWFLAGL
790 800 810
VSWGLGCGRP NFFGVYTRVT RVINWIQQVL T